Introduction: revolutionary changes in the macrolide and azalide antibiotics.
Moellering
R C
RC
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts 02215.
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017963:Azithromycin; D001424:Bacterial Infections / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D017963:Azithromycin